Annual CAPEX
$38.00 K
-$535.00 K-93.37%
December 31, 2022
Summary
- As of February 10, 2025, AGLE annual capital expenditures is $38.00 thousand, with the most recent change of -$535.00 thousand (-93.37%) on December 31, 2022.
- During the last 3 years, AGLE annual CAPEX has fallen by -$1.45 million (-97.45%).
Performance
AGLE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2023
Summary
- AGLE quarterly capital expenditures is not available.
Performance
AGLE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2023
Summary
- AGLE TTM capital expenditures is not available.
Performance
AGLE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
AGLE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -93.4% | - | - |
| 3 y3 years | -97.5% | - | - |
| 5 y5 years | -93.9% | - | - |
AGLE CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -93.4% | at low | ||||
| 5 y | 5-year | -99.1% | at low | ||||
| alltime | all time | -99.1% | at low |
Aeglea BioTherapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $38.00 K(-93.4%) | $0.00(-100.0%) | $38.00 K(0.0%) |
| Sep 2022 | - | $1000.00(>+9900.0%) | $38.00 K(-70.8%) |
| Jun 2022 | - | $0.00(-100.0%) | $130.00 K(-18.8%) |
| Mar 2022 | - | $37.00 K(>+9900.0%) | $160.00 K(-72.1%) |
| Dec 2021 | $573.00 K(-86.6%) | $0.00(-100.0%) | $573.00 K(-63.6%) |
| Sep 2021 | - | $93.00 K(+210.0%) | $1.57 M(-23.1%) |
| Jun 2021 | - | $30.00 K(-93.3%) | $2.05 M(-38.8%) |
| Mar 2021 | - | $450.00 K(-55.0%) | $3.34 M(-21.9%) |
| Dec 2020 | $4.28 M(+186.9%) | $1.00 M(+76.7%) | $4.28 M(-3.9%) |
| Sep 2020 | - | $566.00 K(-57.3%) | $4.45 M(+10.5%) |
| Jun 2020 | - | $1.32 M(-4.6%) | $4.03 M(+45.9%) |
| Mar 2020 | - | $1.39 M(+18.3%) | $2.76 M(+85.2%) |
| Dec 2019 | $1.49 M | $1.17 M(+721.0%) | $1.49 M(+186.4%) |
| Sep 2019 | - | $143.00 K(+150.9%) | $521.00 K(+8.8%) |
| Jun 2019 | - | $57.00 K(-51.7%) | $479.00 K(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $118.00 K(-41.9%) | $457.00 K(+8.3%) |
| Dec 2018 | $422.00 K(-31.8%) | $203.00 K(+101.0%) | $422.00 K(+2.9%) |
| Sep 2018 | - | $101.00 K(+188.6%) | $410.00 K(-2.4%) |
| Jun 2018 | - | $35.00 K(-57.8%) | $420.00 K(-2.6%) |
| Mar 2018 | - | $83.00 K(-56.5%) | $431.00 K(-30.4%) |
| Dec 2017 | $619.00 K(+192.0%) | $191.00 K(+72.1%) | $619.00 K(+12.8%) |
| Sep 2017 | - | $111.00 K(+141.3%) | $549.00 K(+25.3%) |
| Jun 2017 | - | $46.00 K(-83.0%) | $438.00 K(-8.9%) |
| Mar 2017 | - | $271.00 K(+124.0%) | $481.00 K(+126.9%) |
| Dec 2016 | $212.00 K(+1.9%) | $121.00 K(>+9900.0%) | $212.00 K(+61.8%) |
| Sep 2016 | - | $0.00(-100.0%) | $131.00 K(-50.6%) |
| Jun 2016 | - | $89.00 K(+4350.0%) | $265.00 K(+32.5%) |
| Mar 2016 | - | $2000.00(-95.0%) | $200.00 K(+1.0%) |
| Dec 2015 | $208.00 K | $40.00 K(-70.1%) | $198.00 K(+25.3%) |
| Sep 2015 | - | $134.00 K(+458.3%) | $158.00 K(+558.3%) |
| Jun 2015 | - | $24.00 K | $24.00 K |
FAQ
- What is Aeglea BioTherapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Aeglea BioTherapeutics?
- What is the all time high TTM CAPEX for Aeglea BioTherapeutics?
What is Aeglea BioTherapeutics annual capital expenditures?
The current annual CAPEX of AGLE is $38.00 K
What is the all time high annual CAPEX for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual capital expenditures is $4.28 M
What is Aeglea BioTherapeutics annual CAPEX year-on-year change?
Over the past year, AGLE annual capital expenditures has changed by -$535.00 K (-93.37%)
What is the all time high quarterly CAPEX for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly capital expenditures is $1.39 M
What is the all time high TTM CAPEX for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high TTM capital expenditures is $4.45 M